Streetbeat News

Products Services

ANRO

Alto Neuroscience (NYSE:ANRO) has received an $11.7 million funding award from the Wellcome Trust to advance the development of ALTO-100 in bipolar depression. The funding will support a Phase 2b study involving 200 patients, leveraging a cognitive biomarker approach. Topline data is expected in 2026.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:35 pm

CRVS

Corvus Pharmaceuticals announced a publication in Science Signaling demonstrating that ITK inhibition by Soquelitinib induces anti-inflammatory Treg cells. The study highlights the potential for treating inflammatory autoimmune and allergic diseases.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:35 pm

STSS

Sharps Technology, Inc. (NASDAQ: STSS) has entered into a 5-year sales agreement with a U.S. medical products company, generating over $50M in new revenue for its EU facility. The agreement sells out the 10mL SoloGard production capacity and necessitates expansion to meet future demand.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:34 pm

AMPG

AmpliTech Group has announced the release of new cryogenic power supplies designed for the quantum computing industry. Two models are available for purchase either individually or bundled with cryogenic amplifiers.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:34 pm

MIRM

Mirum Pharmaceuticals (NASDAQ:MIRM) received FDA approval for a label expansion of LIVMARLI® (maralixibat) oral solution, now approved for treating cholestatic pruritus in PFIC patients aged 12 months and older. The approval also includes a higher concentration formulation evaluated in the MARCH Phase 3 study.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:33 pm

MAMO

Massimo Group has launched the GKD 350 All-Terrain Go Kart in response to high demand from major retail partners.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:32 pm

LLY

NVO

Eli Lilly and Novo Nordisk shares are trading lower after competitor Viking announced the advancement of its obesity candidate.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:26 pm

F

Ford Motor Co. (NYSE:F) will focus on smaller, affordable electric vehicles (EVs) even if former President Donald Trump wins the 2024 presidential elections. CEO Jim Farley emphasized that larger EVs exert more pressure on margins and that the company aims to develop EVs priced under $40,000 or even $30,000. Despite a $1.14 billion EBIT loss in the second quarter for its EV segment, Ford remains committed to its EV strategy, aiming to be competitive with Chinese manufacturers and Tesla.

Portfolio Pulse from Anan Ashraf

July 25, 2024 | 12:23 pm

VKTX

Viking Therapeutics shares are trading higher after the company announced the advancement of VK2735 to Phase 3.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:20 pm

AZN

REGN

SNY

Sanofi SA (NASDAQ:SNY) reported strong Q2 earnings with a business operating income of $3.03 billion, up 3.2% YoY. Sales of $11.57 billion beat estimates, driven by the blockbuster drug Dupixent, which saw a 29.2% increase in sales. Sanofi raised its 2024 profit outlook, expecting stable business EPS and mid-single-digit growth in vaccine sales.

Portfolio Pulse from Vandana Singh

July 25, 2024 | 12:20 pm